CinCor Pharma, Inc. (CINC) has 14 open-market insider trades by 10 insiders since 2022. The most active filer is James Healy, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| General Atlantic Genpar (bermuda), L.P. | 10% Owner | — | 2 | $29.7M | 2022-08-11 |
| James Healy | Dir10% Owner | — | 3 | $20.5M | 2023-02-24 |
| 5AM Partners VI, LLC | 10% Owner | — | 1 | $18.0M | 2022-08-15 |
| Kush Parmar | 10% Owner | — | 1 | $7.5M | 2022-01-11 |
| Sofinnova Partners SAS | 10% Owner | — | 1 | $4.0M | 2022-08-15 |
| Sofinnova Capital IX | 10% Owner | — | 1 | $3.5M | 2022-01-11 |
| Marc de Garidel | CEO | — | 1 | $200K | 2023-02-24 |
| Mason Freeman | Chief Medical Officer | — | 2 | $42K | 2023-02-24 |
| Catherine Pearce | COO | — | 1 | $36K | 2023-02-24 |
| Mary Theresa Coelho | EVP CFO & Chief BD Officer | — | 1 | $2K | 2022-01-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| James Healy | Director & 10% Owner | Sell | $86K | 2022-11-28 |
| 5AM Partners VI, LLC | 10% Owner | Buy | $18.0M | 2022-08-15 |
| Sofinnova Partners SAS | 10% Owner | Buy | $4.0M | 2022-08-15 |
| General Atlantic Genpar (bermuda), L.P. | 10% Owner | Buy | $2.5M | 2022-08-11 |
| James Healy | Director & 10% Owner | Buy | $15.2M | 2022-08-11 |
| Mason Freeman | Chief Medical Officer | Sell | $91 |
Companies that share insiders with CINC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2022-06-10 |
| Mary Theresa Coelho | EVP CFO & Chief BD Officer | Buy | $2K | 2022-01-11 |
| Mason Freeman | EVP Clinical Development | Buy | $42K | 2022-01-11 |
| Catherine Pearce | COO | Buy | $36K | 2022-01-11 |
| James Healy | Director & 10% Owner | Buy | $5.2M | 2022-01-11 |
| Kush Parmar | 10% Owner | Buy | $7.5M | 2022-01-11 |
| General Atlantic Genpar (bermuda), L.P. | 10% Owner | Buy | $27.2M | 2022-01-11 |
| Sofinnova Capital IX | 10% Owner | Buy | $3.5M | 2022-01-11 |
| Marc de Garidel | CEO | Buy | $200K | 2022-01-11 |